Aggregation and fi bril formation of the amyloid-b (A b ) peptides play a pivotal role in the pathogenesis of Alzheimer's disease (AD). The missing links on the pathway to A b oligomerization, fi bril formation, and neurotoxicity in AD remain the identity of the toxic A b species and mechanism(s) of their toxicity. Such information is crucial for the development of mechanism-based therapeutics to treat AD and tools to diagnose and/or monitor the disease progression. Herein, we describe a simple approach that combines standard biophysical methods with cell biology assays to correlate the aggregation state of A b peptides with their cytotoxicity in vitro. The individual assays are well-established, commonly used, rely on easily accessible materials and can be performed within 24 h. 
Introduction
residues (A b 40 and A b 42), which densely populate the core of the neuritic plaques in AD neuropathology ( 3 ) . During the in vitro fi bril formation of A b peptides, various nonfi brillar aggregates of diverse morphologies and heterogeneous size distributions, collectively known as the soluble oligomers, have been observed. Some of the well-characterized A b oligomer species include protofi brils ( 4 ) , A b -derived diffusible ligands (ADDLs) ( 5 ) , annular oligomers ( 6 ) , and the low molecular weight oligomers ( 7 ) .
Several independent lines of evidence indicate that the soluble oligomers and/or the process of oligomerization (8) (9) (10) , rather than plaque-associated fi brils, are the primary cause of neurodegeneration in AD: (1) Soluble A b , rather than total (soluble and insoluble) A b , levels correlate better with AD progression ( 11, 12 ) ; (2) Signifi cant functional defi cits in the memory performance tasks are observed in the APP transgenic animals long before the emergence of amyloid plaques ( 13, 14 ) ; (3) Soluble A b oligomer preparations, upon intracerebral infusion, induce transient memory defi cits in experimental animals ( 15 ) ; (4) Rare mutations in the APP gene [e.g., arctic mutation (E22G)], which enhance A b oligomerization without altering the total A b levels, are associated with the development of familial AD ( 16 ) ; (5) A b oligomer and protofi bril preparations alter neuronal metabolism ( 17 ) , induce changes in neuronal electrophysiology ( 18 ) and lead to neurotoxicity towards cultured neurons ( 10, 17, 19 ) . Therefore, inhibiting A b oligomerization, by attenuating its production and/or promoting the clearance of toxic A b oligomers from brain, has emerged as potential therapeutic strategies for treating AD ( 20 ) .
Cultured primary neurons and/or cell lines provide easy and economic means of investigating the role of A b aggregation state and the mechanism of A b toxicity, and also as valuable tools for the screening of the inhibitors of A b toxicity in vitro. This chapter describes simple, inexpensive, and reproducible methods which would allow the investigators to assess the toxicity of A b preparations (soluble or insoluble) and correlating A b aggregation/ fi brillization with its cytotoxicity. The general outline is provided in Fig. 1 . Briefl y, cultured cells are treated with purifi ed A b preparations (monomers, protofi brils, and fi brils) or crude preparations containing mixtures of heterogeneous A b species. For detailed protocols on the preparation of these species, the reader is referred to our previous work ( 10, 21 ) . At desired intervals, cell viability is determined by the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) reduction assay. In the case of primary neurons, subtle changes in neuronal viability can also be quantifi ed using immunostaining for neuronal nuclei (NeuN) ( 8 ) or via quantifi cation of the loss of neuronal processes ( 19, 21 ) . In addition, media aliquots of A b -treated cultured cells can be used to investigate the cytotoxicity and the aggregation state of A b simultaneously. Quantitative cytotoxicity information can be obtained by performing the lactate dehydrogenase (LDH) release assay using the cell culture medium. Finally, a direct link between the extent of cytotoxicity and A b aggregation state can be established by combining these assays with methods that allow monitoring of A b aggregation in the cultured media, e.g., dye [Thiofl avin T (ThT)] binding and negative-staining transmission electron microscopy (TEM).
This approach will allow the researchers to closely monitor changes in the quaternary structure of A b under cell culture ( 21 ) . At selected intervals, cell viability can be assessed by the MTT reduction assay. In the case of neuronal cultures, immunostaining for neuronal nuclei (NeuN) ( 8 ) or neuronal processes ( 19 ) can also be used. The culture medium can be assayed for cytotoxicity using the LDH release method. In addition, A b aggregation and fi brillization can be monitored by ThT dye binding and TEM analysis of the culture medium and allow for the correlation of the A b aggregation with the relative cytotoxicity (the MTT graph and the LDH release graphs are reprinted with copyright permission ( 10, 19 ) conditions, formation of oligomers and fi brils during the duration of the experiment, and most importantly, directly correlate A b aggregation state(s) with relative cytotoxicity. The knowledge gathered from such studies is indispensable for the identifi cation of the critical stages (aggregation states) on the A b amyloid formation pathway which underlie A b cytotoxicity and help design the intervention strategies. Herein, we describe the use of MTT reduction and the LDH release assays for quantifying A b toxicity toward cultured PC12 cells. Detailed methods for culturing primary neurons, including immunostaining and measuring cell viability by relevant assays, have been described elsewhere ( 8, 21 ) .
MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] belongs to the group of tetrazolium salts which, upon endocytosis by the cells, is reduced to the insoluble formazan crystals principally by the activity of the mitochondrial respiratory chain enzymes ( 22 ) . In addition, certain enzymes in cytoplasm, endosomes/lysosomes, and plasma membrane have also been implicated in the metabolism of MTT into the formazan ( 23 ) . Metabolically active and viable cells can reduce the MTT in short durations of time, e.g., 30 min, into purple formazan products the formation of which can be monitored spectrophotmetrically ( Fig. 2 ) ( 23 ) . It is one of the most commonly used assays to monitor cytotoxicity of various drugs, synthetic polymers, and amyloid proteins ( 17, 24, 25 ) . Numerous research groups have shown that A b preparations containing monomers, oligomers, or fi brils consistently impair the ability of cultured neurons or other cells to metabolize MTT ( 9, 17, 26 ) . The simple nature of the assay and the lack of requirements for expensive instrumentation make it a convenient choice for assessing the relative toxicity of A b preparations and also for the evaluation of the A b aggregation inhibitors in rescuing the survival of A b -treated cells.
MTT Reduction Assay
Although it is very easy to perform, some shortcomings of the assay are worth mentioning: (1) the assay does not differentiate between cell death and metabolic stress ( 27 ) ; (2) the readout is semiquantitative, i.e., a decrease in MTT reduction does not correlate with number of dead cells in a linear fashion ( 27 ) ; (3) different cell types metabolize MTT, and related tetrazolium dyes, to differential extent, i.e., the assay readout is infl uenced by the metabolic phenotype of the cells ( 28 ) ; and (4) it has also been suggested that amyloidogenic proteins interfere with crystallization of MTT formazan in a manner such that the extent of cytotoxicity is overestimated ( 9 ) . Therefore, it is highly recommended that MTT reduction assay be used in conjunction with some other biochemical and/or immunocytochemical means of assessing the cell viability, e.g., LDH release assay (see below) and/or, in the case of neurons, staining for the loss of neuronal processes.
LDH is an oxidoreductase enzyme present in the cytoplasm of a wide variety of cells and catalyzes the interconversion of pyruvate and lactate, coupled to the concomitant interconversion of NADH and NAD + ( 29, 30 ) . Cell membrane disruption, during various physiological or pathological processes, leads to the release of the enzyme in extracellular milieu (e.g., cell culture medium). Hence, if appropriate substrates are added to the culture medium, the levels of LDH release, and therefore the extent of cell membrane damage, can be quantifi ed (Fig. 3 ) . LDH release is also a commonly used assay for investigating the biosafety of drugs and for assessing the cytotoxicity of the amyloidogenic proteins including A b ( 31, 32 ) . Fig. 3 . Principle of the LDH release assay. Upon membrane disruption/cell damage, the cytosolic LDH is released into the extracellular milieu/tissue culture medium. In the presence of appropriate substrates and cofactors, the enzyme activity results in the formation of colorimetric/fl uorescent products. The latter can be quantifi ed and indicate the extent of cytotoxicity.
LDH Release Assay
Interestingly, it has been observed that in neuronal cultures exposed to A b oligomers, loss of neuronal processes precedes the rise in LDH release. The latter observations suggest that A b oligomer toxicity is mediated by multiple mechanisms and the neurodegeneration commences long before the frank death of neurons ( 9, 10, 18, 19 ) .
In contrast to the MTT reduction assay, the amount of LDH release provides a more reliable measure of the number of dead/ damaged cells ( 33 ) . However, it is also known that different cell types have differential LDH content and/or the kinetics of the LDH release is not identical ( 34 ) ; therefore, correlation of the assay readout to the extent of cell death between different cell types cannot be accurately determined. Nevertheless, the combined application of the two assays (MTT and LDH) provides valuable information regarding both the early and the late events associated with A b cytotoxicity.
Electron microscopy (EM)-based approaches have played important role in our current understanding of the mechanism of amyloid formation of nearly all amyloidogenic proteins, and also in elucidating the structural basis of amyloid toxicity. As early as 1960s, these approaches facilitated the detailed structural characterization of amyloid aggregates associated with neuropathological lesions in AD brains ( 35 ) . In addition, EM methods have also played important role in the discovery and structural characterization of various A b oligomers, including protofi brils, which precede the emergence of fi brils during the aggregation of A b peptides ( 4, 17 ) . The latter fi ndings signifi cantly changed the paradigm of understanding the interrelation of the process of amyloid formation and associated neurodegeneration, and ushered the notion of toxic oligomer/ protofi bril hypothesis ( 36 ) . Although, the toxicity of plaque-associated fi brillar aggregates is not ruled out, this hypothesis points toward soluble A b oligomers as neurotoxins in AD and stipulates that the A b oligomers trigger a complex series of the cellular and molecular events culminating in the development of AD ( 36 ) . A detailed description of various EM-based methods and their utility in studying amyloid aggregation can be found elsewhere ( 21, 37 ) .
Herein, we describe the methods and use of the negative-staining EM on the cell culture media aliquots to study A b aggregation under cell culture conditions, and directly establish the correlation of the aggregate structure with their respective cytotoxicity in neuronal and nonneuronal cell culture systems. In brief, cell culture medium aliquots are deposited on carbon-coated formvar fi lm attached to an EM grid, followed by the staining with a dilute solution of a heavy salt (uranyl acetate, uranyl formate etc.). The latter help enhance the contrast in the images by their ability to scatter electrons in the incident electron beam. Although, a convenient and simple method, the quality of the information obtained by negative-staining EM is limited by certain factors such as: (1) limited resolution capability ( » 2.5 nm) of the technique, (2) drying of the
Negative-Staining TEM
surface causes fl attening of the aggregate structures, (3) the aggregates may differ in their adsorption to the grid surface, (4) image artifacts can be induced by uneven staining of the sample (this could be addressed by preparing multiple grids of the sample), and (5) most importantly, it is not a quantitative method. Therefore, it is suggested that information about the characterization of amyloid aggregates should be complimented by other standard biophysical assays, e.g., Thiofl avin-T (ThT) dye binding and solubility analysis by the size exclusion chromatography ( 6, 8 ) .
Thiofl avin-T (4-(3,6-dimethyl-1,3-benzothiazol-3-ium-2-yl)-N , Ndimethylaniline chloride), and its homologue Thiofl avin-S, is a benzothiazole salt and belongs to the so-called amyloid-specifi c dyes. The thiofl avin dyes undergo red shift in their emission spectrum upon binding to amyloid plaques in amyloid laden tissue sections ( 38, 39 ) . In vitro, thiofl avin dyes bind to the ordered amyloid aggregates such as fi brils and protofi brils of diverse proteins, e.g., A b ( 8, 17 ) , a -synuclein ( 40 ) , but not to the low molecular weight oligomers (2-12 mers) or monomers ( 8, 17 ) . The specifi city of the dyes for binding to the amyloid structures has been proposed to be based on the presence of the cross-strand ladders, characteristic arrangements of side chains, present in b -sheet-rich structures, and formation of channels along the b -sheet surfaces which allow for the binding of linear thiofl avin dyes (Fig. 4 ) ( 41 ) . Although very simple and inexpensive method, ThT binding per se does not always provide a quantitative measure of the amount of amyloid aggregates, e.g., a small amount of fi brils in A b preparations can result in high-ThT values. Also, extensive fi brillization, and intertwining of the fi brils, may reduce the accessibility of ThT dyes towards the binding sites thus erroneously decreasing the ThT readout. Nevertheless, changes in ThT binding in kinetic assays is a reliable indicator of the metastability in amyloid aggregates and, if used in combination with cytotoxicity assays, is a reliable correlate of extent of cytotoxicity with amyloid aggregation. 4. Formvar-coated TEM grids (Electron Microscopy Sciences, cat. no. FCF200-Cu-50). . It is recommended that the cells should be split before they reach complete confl uence (twice/week), to record the number of passages and to keep some frozen stocks of the cells.
Thiofl avin-T Dye Binding

Materials
Detailed methods for the preparation and characterization of the crude A b preparations, containing heterogeneous A b aggregation states and monomers, or defi ned A b species including monomers, protofi brils, and fi brils have been described previously ( 8, 21 ) . 3. Remove 100 ml of the culture medium from each condition and control well and discard into a waste container. 6. At desired intervals (e.g., every hour), carefully remove 150 m l of the culture medium, without touching the well bottom, into sterile microtubes and label accordingly. The removed medium will be used for assays outlined below (Subheadings 3.4 -3.6 ).
Methods
Preparation of
7. Carefully remove the rest of the medium and discard. . These data show that an ongoing process of A b oligomerization and fi brillization, rather than discrete A b species (monomers, protofi brils, or fi brils), critically impairs cell viability ( 9, 10 ) . In other words, dynamics of the protofi bril-monomers interactions and the resultant growth of the protofi brils into fi brils is more important determinant of A b toxicity than relatively stable protofi bril species ( 8, 10 ) . This hypothesis is also supported by the observations that enhancing the kinetic stability of A b 42 protofi brils by adding A b 40 monomers significantly reduces their toxicity toward cultured neurons ( 8 ) . Similarly, small molecules that stabilize A b protofi brils in vitro have also been shown to improve behavioral performance in APP transgenic mice ( 43 ). 7. Record the absorbance at 570 nm using a microplate reader. Use a wavelength in the range of 630-750 nm (e.g., 690 nm) as a reference wavelength to account for the plate background, cell debris, nonspecifi c absorbance etc.
MTT Reduction Assay
8. Plot the data in a suitable software (Figs. 5a and 6a ).
4. Apply a 10 m l droplet of negative-staining solution (e.g., 2% wt/vol. UA) and let it settle for ~60 s on the grid surface (see Note 8).
5. Remove the excess solution as in step 3 above.
LDH Release Assay
Thiofl avin-T Assay
Transmission Electron Microscopy
6. Using a fi ne vacuum probe, gently vacuum dry the grid from the edges. Sample grids not examined immediately can be stored in a storage box in a dry place (e.g., a desiccating chamber).
7. Acquire images on a CM10 TEM (or equivalent TEM), equipped with a CCD camera, operated at an acceleration voltage of 80-100 kV (Figs. 5d-h and 6d , e).
1. Other cell lines of neural origin (e.g., human neuroblastoma SHSY5Y cells) and/or primary neurons can be used as well. For culturing primary neurons, see the methods described elsewhere ( 21 ) .
2. Excessive dilution of A b samples can be avoided by preparing the A b stock samples in supplemented 10× DMEM (e.g., Sigma, cat. no. D2429) ( 10 ) or modifi ed 100× neurobasal medium ( 21 ) .
3. Alternatively, commercially available kits can also be used with appropriate modifi cations to the procedure (e.g., Promega, cat. no. G4000). 7. To reduce the TEM grid surface contamination and hydrophobicity, it is recommended to apply the glow discharge the grids prior to the sample application. 
